214 related articles for article (PubMed ID: 31728854)
1. The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma.
de Almeida Magalhães T; Borges KS; de Sousa GR; Brandalise SR; Seidinger AL; Scrideli CA; Oba-Shinjo SM; Yunes JA; Tone LG
Neurol Sci; 2020 Mar; 41(3):691-694. PubMed ID: 31728854
[TBL] [Abstract][Full Text] [Related]
2. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
[TBL] [Abstract][Full Text] [Related]
3. Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors.
Feitosa JADS; das Chagas PF; de Sousa GR; Queiroz RGP; Cruzeiro GAV; Tone LG; Borges KS; Valera ET
Mol Biol Rep; 2020 Aug; 47(8):6439-6443. PubMed ID: 32671623
[TBL] [Abstract][Full Text] [Related]
4. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
5. MRI Phenotype of RELA-fused Pediatric Supratentorial Ependymoma.
Nowak J; Jünger ST; Huflage H; Seidel C; Hohm A; Vandergrift LA; von Hoff K; Rutkowski S; Pietsch T; Warmuth-Metz M
Clin Neuroradiol; 2019 Dec; 29(4):595-604. PubMed ID: 30027327
[TBL] [Abstract][Full Text] [Related]
6. A novel type of C11orf95-LOC-RELA fusion in a grade II supratentorial ependymoma: report of a case with literature review.
de Sousa GR; Marie SKN; Oba-Shinjo SM; Ramalho LNZ; Tone LG; Valera ET
Childs Nerv Syst; 2019 Apr; 35(4):689-694. PubMed ID: 30631904
[TBL] [Abstract][Full Text] [Related]
7. Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.
Witt DA; Donson AM; Amani V; Moreira DC; Sanford B; Hoffman LM; Handler MH; Levy JMM; Jones KL; Nellan A; Foreman NK; Griesinger AM
Pediatr Blood Cancer; 2018 May; 65(5):e26960. PubMed ID: 29350470
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.
Mastellaro MJ; Seidinger AL; Kang G; Abrahão R; Miranda ECM; Pounds SB; Cardinalli IA; Aguiar SS; Figueiredo BC; Rodriguez-Galindo C; Brandalise SR; Yunes JA; Barros-Filho AA; Ribeiro RC
Cancer; 2017 Aug; 123(16):3150-3158. PubMed ID: 28387921
[TBL] [Abstract][Full Text] [Related]
9. A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods.
de Sousa GR; Lira RCP; de Almeida Magalhães T; da Silva KR; Nagano LFP; Saggioro FP; Baroni M; Marie SKN; Oba-Shinjo SM; Brandelise S; de Paula Queiroz RG; Brassesco MS; Scrideli CA; Tone LG; Valera ET
J Mol Med (Berl); 2021 Aug; 99(8):1101-1113. PubMed ID: 33903940
[TBL] [Abstract][Full Text] [Related]
10. Association of the germline TP53 R337H mutation with breast cancer in southern Brazil.
Assumpção JG; Seidinger AL; Mastellaro MJ; Ribeiro RC; Zambetti GP; Ganti R; Srivastava K; Shurtleff S; Pei D; Zeferino LC; Dufloth RM; Brandalise SR; Yunes JA
BMC Cancer; 2008 Dec; 8():357. PubMed ID: 19046423
[TBL] [Abstract][Full Text] [Related]
11. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
Fukuoka K; Kanemura Y; Shofuda T; Fukushima S; Yamashita S; Narushima D; Kato M; Honda-Kitahara M; Ichikawa H; Kohno T; Sasaki A; Hirato J; Hirose T; Komori T; Satomi K; Yoshida A; Yamasaki K; Nakano Y; Takada A; Nakamura T; Takami H; Matsushita Y; Suzuki T; Nakamura H; Makino K; Sonoda Y; Saito R; Tominaga T; Matsusaka Y; Kobayashi K; Nagane M; Furuta T; Nakada M; Narita Y; Hirose Y; Ohba S; Wada A; Shimizu K; Kurozumi K; Date I; Fukai J; Miyairi Y; Kagawa N; Kawamura A; Yoshida M; Nishida N; Wataya T; Yamaoka M; Tsuyuguchi N; Uda T; Takahashi M; Nakano Y; Akai T; Izumoto S; Nonaka M; Yoshifuji K; Kodama Y; Mano M; Ozawa T; Ramaswamy V; Taylor MD; Ushijima T; Shibui S; Yamasaki M; Arai H; Sakamoto H; Nishikawa R; Ichimura K;
Acta Neuropathol Commun; 2018 Dec; 6(1):134. PubMed ID: 30514397
[TBL] [Abstract][Full Text] [Related]
12. Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil.
Custodio G; Taques GR; Figueiredo BC; Gugelmin ES; Oliveira Figueiredo MM; Watanabe F; Pontarolo R; Lalli E; Torres LF
PLoS One; 2011 Mar; 6(3):e18015. PubMed ID: 21445348
[TBL] [Abstract][Full Text] [Related]
13. C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin.
Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Rajeshwari M; Singh M; Suri V; Sarkar C; Sharma MC
J Neurooncol; 2018 May; 138(1):29-39. PubMed ID: 29354850
[TBL] [Abstract][Full Text] [Related]
14. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
Tauziède-Espariat A; Siegfried A; Nicaise Y; Kergrohen T; Sievers P; Vasiljevic A; Roux A; Dezamis E; Benevello C; Machet MC; Michalak S; Puiseux C; Llamas-Gutierrez F; Leblond P; Bourdeaut F; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Dangouloff-Ros V; Boddaert N; Saffroy R; Hasty L; Wahler E; Pagès M; Andreiuolo F; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
Acta Neuropathol Commun; 2021 Aug; 9(1):135. PubMed ID: 34389065
[TBL] [Abstract][Full Text] [Related]
15. Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome.
Formiga MNDC; de Andrade KC; Kowalski LP; Achatz MI
JAMA Oncol; 2017 Oct; 3(10):1400-1402. PubMed ID: 28114597
[TBL] [Abstract][Full Text] [Related]
16. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
[TBL] [Abstract][Full Text] [Related]
17. Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.
Tzaridis T; Milde T; Pajtler KW; Bender S; Jones DT; Müller S; Wittmann A; Schlotter M; Kulozik AE; Lichter P; Peter Collins V; Witt O; Kool M; Korshunov A; Pfister SM; Witt H
Oncotarget; 2016 Sep; 7(38):61860-61873. PubMed ID: 27556362
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of an inherited cancer predisposition syndrome associated with the germ line TP53 R337H mutation in Paraguay.
Legal EF; Ascurra M; Custódio G; Ayala HL; Monteiro M; Vega C; Fernández-Nestosa MJ; Vega S; Sade ER; Coelho IM; Ribeiro EM; Cavalli IJ; Figueiredo BC
Cancer Epidemiol; 2015 Apr; 39(2):166-9. PubMed ID: 25736369
[TBL] [Abstract][Full Text] [Related]
19. Review of ependymomas: assessment of consensus in pathological diagnosis and correlations with genetic profiles and outcome.
Sasaki A; Hirato J; Hirose T; Fukuoka K; Kanemura Y; Hashimoto N; Kodama Y; Ichimura K; Sakamoto H; Nishikawa R
Brain Tumor Pathol; 2019 Apr; 36(2):92-101. PubMed ID: 30929114
[TBL] [Abstract][Full Text] [Related]
20. Adrenocortical tumors associated with the TP53 p.R337H germline mutation can be identified during child-care consultations.
Mastellaro MJ; Ribeiro RC; Oliveira-Filho AG; Seidinger AL; Cardinalli IA; Miranda ECM; Aguiar SS; Brandalise SR; Yunes JA; Barros-Filho AA
J Pediatr (Rio J); 2018; 94(4):432-439. PubMed ID: 28864397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
